9M, trading at S$0.08 on the SES. This SniperIQ fundamentals page covers Vicplas International's valuation, profitability (net margin -4.8%), revenue (S

What is Vicplas International's P/E ratio?

Vicplas International's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Vicplas International?

Vicplas International runs a net profit margin of -4.8%, a gross margin of 33.3%, and an operating margin of 8.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Vicplas International generate?

Vicplas International reported revenue of S

Does Vicplas International pay a dividend?

Vicplas International does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Vicplas International financially healthy?

Vicplas International carries a debt-to-equity ratio of 0.64x and a current ratio of 1.37x, with a market beta of 0.24. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Vicplas International a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Vicplas International (569) the key facts are: market cap S

9M, revenue S

Track Vicplas International's full fundamentals live

Get Vicplas International's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.